PDCD1 and neoplasm: Innate PROGs were defined as pre-existing metastases that did not undergo tumor shrinkage or new metastases identified within 6 months of starting treatment, and acquired PROGs were defined as pre-existing tumors that initially responded but subsequently progressed on PD-1 inhibitor or new metastases identified after 6 months of starting treatment (Fig. 1A).